Nuvalent Inc (NUVL) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nuvalent Inc   (NASDAQ: NUVL)


Nuvalent Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nuvalent Inc's ROI in the first quarter of 2026?
Nuvalent Inc recorded a cumulative net loss of $-450 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -40.66%.

Within the Healthcare sector 449 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 2510 to 3638.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM 13.73 % 18.97 % 26.17 % 75.27 % 77.55 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,250 1,322 891 965 1,031
Return On Investment (TTM) -40.66 % -40.43 % -38.39 % -32.53 % -30.91 %
NUVL's Overall Ranking # 3638 # 2510 # 3230 # 2869 # 3120
Seq. Investment Change TTM 5.21 % 5.88 % -5.85 % 8.43 % 10.06 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -450 -425 -381 -343 -301

NUVL Company Profile >> Back to NUVL Roi Comparisons >> See Annual NUVL Return On Investment



Return On Investment NUVL's Ranking
Within: No.
Industry # 176
Sector # 450
Overall # 3638

Return On Investment Statistics
High Average Low
-24.29 %
-160.53 %
-1081.16 %
(Mar 31 2022)   (Sep 30 2016)







Financial Statements
Nuvalent Inc's I. Quarter Investments $ 1,250 Millions NUVL's Balance sheet
Nuvalent Inc's I. Quarter Income $ -109 Millions Quarterly NUVL's Income Statement
NUVL's Income by Division See NUVL's Income by Division


NUVL Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,322 1,088 701 463 285
Y / Y Investment Growth 21.49 % 55.27 % 51.32 % 62.43 % 2055.13 %
Net Income in Millions -425 -261 -126 -82 -46
Y / Y Net Income Growth - - - - -
Annual Return On Investment -32.19 % -23.97 % -18.02 % -17.68 % -16.26 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NUVL's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NUVL's Competitors
Subscribers only: Roi for Nuvalent Inc's Suppliers
Subscribers only: Return On Investment for NUVL's Customers

Other Ratios
NUVL's Roa NUVL's Inventory Turnover Ratio NUVL's Growth Rates NUVL's Dividend Statistics
NUVL's Profitability Ratios NUVL's Asset Turnover Ratio NUVL's Dividend Growth
NUVL's Roe NUVL's Valuation Ratios NUVL's Financial Strength Ratios NUVL's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:40:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.